Form 4: Eli Lilly Director Acquires Shares Under Directors' Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly & Co, acquired shares of common stock under the Lilly Directors' Deferral Plan.

Summary

• On January 21, 2025, Mary Lynne Hedley, a director of Eli Lilly & Co, acquired 13.358 shares of common stock at a price of $742.35 per share.
• These shares were acquired under the Lilly Directors' Deferral Plan in lieu of cash compensation and will be settled in shares of common stock following her separation from service.
• Following the transaction, Ms. Hedley directly owns 1,892.323 shares of Eli Lilly common stock.
• She also indirectly owns 98 shares through a trust, but disclaims beneficial ownership except to the extent of her pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares indicates confidence in the company, but it's a routine transaction under a standard compensation plan.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future performance.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

Directors' share acquisitions are common and often viewed positively, indicating alignment with shareholder interests. This transaction is part of a standard director compensation plan.

Comparison to Industry Standards

• Director compensation packages often include stock options or deferred stock units to align their interests with shareholders, similar to practices at companies like Pfizer (PFE) and Merck (MRK).
• The Lilly Directors' Deferral Plan is comparable to deferred compensation plans offered by other large pharmaceutical companies, allowing directors to defer cash compensation into stock units.
• The amount of shares acquired is relatively small, suggesting it's a routine part of the director's compensation rather than a significant investment decision.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Form 4, Director, Share Acquisition, Lilly Directors' Deferral Plan, Common Stock, Eli Lilly, Hedley, LLY